MeSH tree: D03.633.400.686.750.550
During the COVID-19 pandemic, when fentanyl overdoses surged, doctors were desperate to find ways of helping their patients. They knew that buprenorphine could help people stop using opioids, but it was much harder to start ...
Jan 24, 2025
0
50
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with ...
Nov 13, 2024
0
32
It can set in after just a few miles: Nagging aches grow numb, sense of time slips away, colors brighten and thoughts grow crisp. Afterward, runners say they feel less anxious, stronger and more confident—even euphoric.
Oct 24, 2024
0
12
A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the nation offered any form of medication for opioid use disorder, and ...
Sep 24, 2024
0
46
Researchers from The University of Western Australia have found medications used to treat alcohol use disorders are severely underutilized in Australia.
Sep 10, 2024
0
22
In a world still grappling with the aftermath of the COVID-19 pandemic, a team of international researchers has proposed a novel approach to treating the persistent symptoms that plague many survivors of viral infections. ...
Sep 3, 2024
0
54
There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment facilities, according to a study published online July 11 in the JAMA.
Jul 16, 2024
0
26
Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows.
Jun 27, 2024
1
58
In France, the majority of people with an opioid use disorder—87%—receive access to medication designed to treat it. In the United States, where more than 100,000 people are dying annually from drug overdoses, less than 20% ...
Jun 20, 2024
0
45
A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment, UCLA-led research suggests.
Jun 10, 2024
0
57
